Recombinant Human STAT1 PRODUCT ANALYSIS SHEET Catalog Number: PHF0011 Lot Number: 1397177 Quantity: 100 g Molecular Weight: ~ 90 kDa Purity: >95% as determined by SDS-PAGE analysis. Biological Activity: Recombinant human STAT1 is phosphorylatable in vitro, using either immunoprecipitated JAK1 or JAK2, or whole cell extracts derived from interferon-γstimulated HEK 293 cells. This phosphorylation can be monitored by Western blot analysis using BioSource’s phosphorylation site specific antibody directed to STAT [pY701] (Catalog # 44-378), in conjunction with chemiluminescence detection methods. Optimization of the cell stimulation protocol, cell lysis procedure, and reaction conditions may be required for each specific application. Formulation: Lyophilized, carrier protein-free. Sterility: Filtered through a 0.22 micron sterile filter. Production: Recombinant Human STAT1 was produced in E. coli with an amino-terminal polyhistidine tag and purified via sequential chromatography. Reconstitution Recommendation: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute lyophilized recombinant human STAT1 in 10 mM Tris, pH 7.5, to a concentration of 0.2-1.0 mg/mL. Suggested Working Dilutions: The optimal concentration should be determined for each specific application. Expiration Date: Expires one year form date of receipt when stored as instructed. Storage: Store lyophilized recombinant human STAT1 at 2-8C, preferably desiccated. Upon reconstitution, apportion the solution into working aliquots. STAT1 solutions are stable at 4C for up to 2 weeks. For maximal stability, store the aliquots at <-20C. Avoid repeated freeze/thaw cycles. References: Schindler, C., X.Y. Fu, T. Improta, R. Aebersold, and J.E. Darnell Jr. (1992) Proteins of transcription factor ISGF-3: One gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc. Nat’l. Acad. Sci. U.S.A. 89:7836-7839. Quelle, F.W., W. Thierfelder, B.A. Witthuhn, B. Tang, S. Cohen, and J.N. Ihle (1995) Phosphorylation and activation of the DNA binding activity of purified STAT1 by the This product is for research use only. Not for use in diagnostic procedures. www.invitrogen.com Manufactured under ISO 13485 Quality Standard Invitrogen Corporation • 542 Flynn Rd • Camarillo • CA 93012 • Tel: 800.955.6288 • E-mail: techsupport@invitrogen.com PI PHF0011 (Rev 1.1) (DCC-08-1232) Important Licensing Information - These products may be covered by one or more Limited Use Label Licenses (see the Invitrogen Catalog or our website, www.invitrogen.com). By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use. Janus protein-tyrosine kinases and the epidermal growth factor receptor. J. Biol. Chem. 270:20775-20780. References (cont’d): Greenlund, A.C., M.O Morales, B.L. Viviano, H. Yan, J. Krolewski, and R.D. Schrieiber (1995) STAT recruitment by tyrosine-phosphorylated cytokine receptors: An order reversible affinity-driven process. Immunity 2:677-687. Vignais, M-L. and M. Gilman (1999) Distinct mechanisms of activation of STAT1 and STAT3 by platelet-derived growth factor receptor in a cell-free system. Mol. Cell Biol. 19:3727-3735. Wang, Y., T.R. Wu, S. Cai, T. Welte, and Y.E. Chen (2000) STAT1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol. Cell. Biol. 20:4505-4512. Bromberg, J. and X. Chen (2001) STAT proteins: Signal transducers and activators of transcription. Methods Enzymol. 333:138-151. Nair, J.S., C.J. DaFonseca, A. Tjernberg, W. Sun, J.E. Darnell Jr., B.T. Chait, and J.J. Zhang (2002) Requirement of Ca2+ and CaMKII for STAT1 Ser-727 phosphorylation in response to IFN-gamma. Proc. Nat’l. Acad. Sci. U.S.A. 99:5971-5976. Levy, D.E. and J.E. Darnell Jr. (2002) STATs: Transcriptional control and biological impact. Nat. Rev. Mol. Cell. Biol. 3:651-662. kDa 100- 1 2 75- 1 2 - STAT1 50STAT1 pan antibody STAT1 [pY701] antibody (Cat. # 44-360) (Cat. # 44-378) In vitro activation of recombinant STAT1. Western blot analysis of recombinant STAT1 incubated with unstimulated (Lane 1) and IFN--stimulated (Lane 2) HEK 293 cell extracts in a standard kinase reaction. Recombinant STAT1 was purified by batch binding to Ni-NTA agarose, washed, and eluted with SDS-sample buffer and electrophoresed on a 7.5% SDS PAGE gel. Proteins were transferred to PVDF membranes and incubated with 1 g/mL of STAT1 pan antibody (Catalog # 44-360) or STAT1 [pY701] phosphorylation site specific antibody (Catalog # 44-378). The signal was detected using a goat anti-rabbit IgG alkaline phosphatase conjugated antibody (Catalog # ALI4405) at a 1:5000 dilution and the membrane was incubated with CDP-substrate using the WesternStarTM method (Tropix). The membrane was then exposed to Kodak BioMax film. For detailed procedures and reaction conditions, please see: http://www.biosource.com/content/catalogContent/tds3/moreinfo/STAT1%20activation1.pdf This product is for research use only. Not for use in diagnostic procedures. www.invitrogen.com Manufactured under ISO 13485 Quality Standard Invitrogen Corporation • 542 Flynn Rd • Camarillo • CA 93012 • Tel: 800.955.6288 • E-mail: techsupport@invitrogen.com PI PHF0011 (Rev 1.1) (DCC-08-1232) Important Licensing Information - These products may be covered by one or more Limited Use Label Licenses (see the Invitrogen Catalog or our website, www.invitrogen.com). By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.